The global viscosupplementation market size reached US$ 4.1 Billion in 2022. Looking forward, the analyst expects the market to reach US$ 6.8 Billion by 2028, exhibiting a CAGR of 8.8% during 2022-2028. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.
Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.
Viscosupplementation Market Trends:
The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.
Key Market Segmentation:
The analyst provides an analysis of the key trends in each segment of the global viscosupplementation market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type, age group, distribution channel, application and end use.
Type Insights:
- Single Injection
- Three Injection
- Five Injection
The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.
Age Group Insights:
- Adults
- Geriatrics
A detailed breakup and analysis of the viscosupplementation market based on the age group has also been provided in the report. This includes adults and geriatric. According to the report, geriatrics accounted for the largest market share.
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The report has also provided a detailed breakup and analysis of viscosupplementation market based on the category. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.
Application Insights:
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand Osteoarthritis
- Others
A detailed breakup and analysis of the viscosupplementation market based on the material type has also been provided in the report. This includes knee, hip and hand osteoarthritis. According to the report, knee osteoarthritis accounted for the largest market share.
End Use Insights:
- Hospitals
- Orthopedic Clinics
- Others
The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global viscosupplementation market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global viscosupplementation market?
- What are the key regional markets?
- Which countries represent the most attractive viscosupplementation markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the age group?
- What is the breakup of the market based on the distribution channel?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What is the competitive structure of the global viscosupplementation market?
- Who are the key players/companies in the global viscosupplementation market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Viscosupplementation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Single Injection
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Three Injection
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Five Injection
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Age Group
7.1 Adults
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Geriatrics
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Application
9.1 Knee Osteoarthritis
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hip Osteoarthritis
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hand Osteoarthritis
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End Use
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Orthopedic Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 Drivers, Restraints, and Opportunities
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Anika Therapeutics Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Aptissen S.A.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Bioventus LLC
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Ferring Pharmaceuticals
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Fidia Farmaceutici S.p.A.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Johnson & Johnson
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 LG Chem Ltd.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 OrthogenRx Inc. (Avanos Medical Inc.)
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Sanofi S.A.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Seikagaku Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.11 Virchow Biotech Private Limited
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Zimmer Biomet
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
Figure 1: Global: Viscosupplementation Market: Major Drivers and Challenges
Figure 2: Global: Viscosupplementation Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Viscosupplementation Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Viscosupplementation Market: Breakup by Type (in %), 2022
Figure 5: Global: Viscosupplementation Market: Breakup by Age Group (in %), 2022
Figure 6: Global: Viscosupplementation Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Viscosupplementation Market: Breakup by Application (in %), 2022
Figure 8: Global: Viscosupplementation Market: Breakup by End Use (in %), 2022
Figure 9: Global: Viscosupplementation Market: Breakup by Region (in %), 2022
Figure 10: Global: Viscosupplementation (Single Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Viscosupplementation (Single Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Viscosupplementation (Three Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Viscosupplementation (Three Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Viscosupplementation (Five Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Viscosupplementation (Five Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Viscosupplementation (Adults) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Viscosupplementation (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Viscosupplementation (Geriatrics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Viscosupplementation (Geriatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Viscosupplementation (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Viscosupplementation (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Viscosupplementation (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Viscosupplementation (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Viscosupplementation (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Viscosupplementation (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Viscosupplementation (Knee Osteoarthritis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Viscosupplementation (Knee Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Viscosupplementation (Hip Osteoarthritis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Viscosupplementation (Hip Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Viscosupplementation (Hand Osteoarthritis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Viscosupplementation (Hand Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Viscosupplementation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Viscosupplementation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Viscosupplementation (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Viscosupplementation (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Viscosupplementation (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Viscosupplementation (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Viscosupplementation (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Viscosupplementation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Viscosupplementation Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Viscosupplementation Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Viscosupplementation Industry: Drivers, Restraints, and Opportunities
Figure 90: Global: Viscosupplementation Industry: Value Chain Analysis
Figure 91: Global: Viscosupplementation Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Viscosupplementation Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Viscosupplementation Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Viscosupplementation Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
Table 4: Global: Viscosupplementation Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Viscosupplementation Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Viscosupplementation Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 7: Global: Viscosupplementation Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Viscosupplementation Market: Competitive Structure
Table 9: Global: Viscosupplementation Market: Key Players
Companies Mentioned
- Anika Therapeutics Inc.
- Aptissen S.A.
- Bioventus LLC
- Ferring Pharmaceuticals
- Fidia Farmaceutici S.p.A.
- Johnson & Johnson
- LG Chem Ltd.
- OrthogenRx Inc. (Avanos Medical Inc.)
- Sanofi S.A.
- Seikagaku Corporation
- Virchow Biotech Private Limited
- Zimmer Biomet
- Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
Methodology
LOADING...
